Two drugs vs. one: Real-World test for bowel disease control
NCT ID NCT07442045
Summary
This study looks back at the medical records of 150 adults with moderate-to-severe ulcerative colitis (UC) to see which treatment approach worked better in real life. It compares patients who took a pill called upadacitinib by itself to those who took that same pill along with an infusion drug called vedolizumab. The goal is to see which group had better control of their disease symptoms and fewer side effects after 8 weeks of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
the Sixth Affiliated Hospital of Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 501655, China
Conditions
Explore the condition pages connected to this study.